{"nct_id":"NCT01702428","title":"Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M-M-R II), in Children 12 to 15 Months of Age","status":"COMPLETED","status_verified_date":"2019-11","start_date":"2012-11-09","start_date_type":"ACTUAL","primary_completion_date":"2014-11-25","primary_completion_date_type":"ACTUAL","completion_date":"2015-04-16","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}